Literature DB >> 1731570

Maximal exercise testing in single and double lung transplant recipients.

T J Williams1, G A Patterson, P A McClean, N Zamel, J R Maurer.   

Abstract

Patients with end-stage pulmonary and pulmonary vascular disease can now be offered single-lung (SLT), double-lung (DLT), or heart-lung (HLT) transplantation. Long-term survival with greatly improved pulmonary function has been reported with all three procedures. Little has been reported of the exercise capacity after transplantation. This report documents Stage 1 exercise test results in six SLT (five males and one female; age 50.7 +/- 4.4; FEV1.0 75.5 +/- 6.7% of predicted) and seven DLT (three males and four females; age 37.3 +/- 6.7; FEV1.0 85.1 +/- 10.3% of predicted) recipients, early (3 months) and late (1 to 2 yr) following transplantation. The results show low work rates and VO2max in both SLT and DLT recipients at 3 months after transplant. Heart rate and minute ventilation did not appear limiting. There was no significant improvement when retested 1 to 2 yr after transplant. At 3 months, VO2max was 46% of predicted for SLT and 50% of predicted for DLT recipients. It is concluded that considerable exercise limitation persists after transplantation and does not appear to improve with time. These limitations are similar for both SLT and DLT and are not related to ventilation. The results may suggest chronic muscle deconditioning after long-term pretransplant debilitation.

Entities:  

Mesh:

Year:  1992        PMID: 1731570     DOI: 10.1164/ajrccm/145.1.101

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

Review 1.  Surgery and the respiratory muscles.

Authors:  N M Siafakas; I Mitrouska; D Bouros; D Georgopoulos
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 2.  Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.

Authors:  Namrata Patel; Malcolm DeCamp; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

3.  Comparison of the functional results of single lung transplantation for pulmonary fibrosis and chronic airway obstruction.

Authors:  R A Chacon; P A Corris; J H Dark; G J Gibson
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

Review 4.  Aspects of skeletal muscles in chronic respiratory disease.

Authors:  William D-C Man
Journal:  Chron Respir Dis       Date:  2016-08       Impact factor: 2.444

Review 5.  Outcomes after lung transplantation.

Authors:  Gabriel Thabut; Herve Mal
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 7.  Heart-lung transplantation: pediatric indications and outcomes.

Authors:  Jonathan E Spahr; Shawn C West
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

8.  Skeletal muscle strength and endurance in recipients of lung transplants.

Authors:  Sunita Mathur; Robert D Levy; W Darlene Reid
Journal:  Cardiopulm Phys Ther J       Date:  2008-09

Review 9.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

Review 10.  Cystic fibrosis.

Authors:  M R Bye; J M Ewig; L M Quittell
Journal:  Lung       Date:  1994       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.